<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas13513-bib-0008">
 <label>8</label>
 <mixed-citation publication-type="journal" id="cas13513-cit-0008">
  <string-name>
   <surname>O'Connor</surname>
   <given-names>OA</given-names>
  </string-name>, 
  <string-name>
   <surname>Horwitz</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Masszi</surname>
   <given-names>T</given-names>
  </string-name>, et al. 
  <article-title>Belinostat in patients with relapsed or refractory peripheral T‐cell lymphoma: results of the pivotal phase II BELIEF (CLN‐19) study</article-title>. 
  <source>J Clin Oncol</source>. 
  <year>2015</year>;
  <volume>33</volume>:
  <fpage>2492</fpage>‐
  <lpage>2499</lpage>.
  <pub-id pub-id-type="pmid">26101246</pub-id>
 </mixed-citation>
</ref>
